AFFORD I and II Projects
The AFFORD Project, 2005-2010, was a five-year health marketing program in Kampala, Uganda. CCP served as the lead contractor, partnering with the Futures Group, the Malaria Consortium, DCFU, PULSE, and Aclaim in order to manage program activities and establish an independent Ugandan entity, the Uganda Health Management Group (UHMG).
In 2010, USAID /Uganda awarded a three year follow-on agreement, AFFORD II, 2011-2014, to Johns Hopkins University (JHU). This second phase was led by Johns Hopkins University Center for Communication Programs (JHUCCP) in partnership with Uganda Health Marketing Group (UHMG) with a mission to integrate health communication and social marketing techniques to address a variety of health issues and behaviors in Uganda, and an overarching aim of strengthening the institution of UHMG from an organization primarily dependent upon USAID funding to a private sector institution that is self-financing, self-governing and meeting its goal of contributing to improved health status of Ugandans through social marketing.
Project materials here
- The ECHO Study Report
- Creating Mobile Health Solutions for Behaviour Change: A Study of Eight Services in the mNutrition Initiative Portfolio
- Reaching First-Time Parents and Young Married Women for Healthy Timing and Spacing of Pregnancies in Burkina Faso
- Lever les Tabous: La sexualité et les approches promouvant l’égalité des genres pour mettre fin aux unions et aux mariages d’enfants, précoces et forcés
- HIV and Sexual and Reproductive Health Programming: Innovative Approaches to Integrated Service Delivery
- Community Communication MNCH e-Manual: Participatory Health Promotion Sessions
- Transforming the Private Sector to Support Universal Malaria Diagnostic Coverage
- HTSP Project Briefs: Niger, Togo
- “Because my Husband and I Have Never Had a Baby Before…” Results and Lessons from Interventions with First-Time Parents in Madagascar, Mozambique, and Nigeria
- Hormonal Contraceptive Eligibility for Women at High Risk of HIV: Guidance Statement